Novalis Biotech — Full Portfolio
20 tracked investments · listed companies and verified rows first
Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development.
AgTechBiotechDeep TechHealthtechLausanne, CH
Riccardo Dainese(CCO and Co-founder)inDaniel Alpern(CSO and Co-founder)in
Co-investorsKickfund
C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring.
Digital HealthHealthtechMedical DevicesCaparica, PT
Co-investorsBoehringer Ingelheim Venture FundPortugal Ventures
Carroucell develops microcarrier technology for cell and gene therapy applications, enabling cost-effective bioproduction and cell amplification.
BiotechDeep TechMedical DevicesGrenoble, FR
Clouds of Care develops EEG and electrophysiology-based digital health technology and software (including FDA-cleared/CE-marked SaMD) to provide meaningful endpoints for clinical development in CNS disorders such as epilepsy and sleep disorders.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsPMVWhite Fund
HealthtechBoise, US
Walter De Brouwer(Executive Officer, Director)Hassinger David(Executive Officer)Ming-Wai Chung(Executive Officer)Alan Greene(Executive Officer)
Co-investorsComet LabsPantera Capital
Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEindhoven, NL
Wim van den Broek(CEO)inWaander(CSO)
Co-investorsi&i Biotech FundOost NLTakeda Ventures
Fertiga is a biotech company that develops diagnostic tools to improve IVF success rates.
BiotechDigital HealthFemTechHealthtechMedical DevicesBrussels, BE
Prof. Dr. Johan Smitz(Co-founder & Chief Medical Officer)Ir. Elien Van Hecke(Co-founder & Chief Executive Officer)Prof. Dr. André Rosenthal(Co-founder & Board member)
Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS.
AI & Machine LearningDigital HealthHealthtechMedical Devices
David Suendermann-Oeft(Co-founder & CEO)inDavid Pautler(Co-founder & CTO)in
Co-investorsCARELA Holding GmbHLair East Labs
myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs.
AI & Machine LearningBiotechHealthtechSaaS
BoardCedric BogaertinJan Van Den BergheinWim van Criekingein
Peggy is a social marketplace app for buying, selling, and discovering contemporary art, serving artists, galleries, and collectors.
ConsumerE-commerceFintechMarketplacesMedia & Entertainment
Adam Meghji(Co-Founder)inCraig Follett(Co-Founder & CEO)in
Co-investorsBackbone AngelsEntrepreneur VenturesGarage CapitalZ Venture CapitalNomad Capital
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications.
BiotechDeep TechDigital HealthHealthtechMedical DevicesUppsala, SE
Lei Chen(Co-Founder & CTO)inUlf Landegren(Co-Founder & Board Member)Per Matsson(Co-Founder & Chairman of the Board)in
Co-investorsNavigare Ventures
RheaVita manufactures scalable freeze-dryer systems for pharmaceutical and vaccine development, ranging from R&D models to GMP-compliant production units.
Advanced ManufacturingBiotechDeep TechHardwareMedical DevicesGhent, BE
Jos Corver(Co-founder)inThomas De Beer(CEO)in
Co-investorsPMV
RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease.
AI & Machine LearningHealthtechMedical Devices
Nicolaas Fosselle(Founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
H42 Inc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







































